1 / 30

Inhibition of rabies virus replication by microRNA

Inhibition of rabies virus replication by microRNA. N.ISRASENA , N. RATANASETYUTH , P. SUPAVONWONG, P. VIROJANAPIROM, T.HEMACHUDHA  Department of Pharmacology, Chulalongkorn University Hospital. Queen Saovabha Memorial Institute, Thai Red Cross Society, Bangkok, Thailand .

lida
Download Presentation

Inhibition of rabies virus replication by microRNA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Inhibition of rabies virus replication by microRNA N.ISRASENA, N. RATANASETYUTH, P.SUPAVONWONG, P. VIROJANAPIROM, T.HEMACHUDHA  Department of Pharmacology, Chulalongkorn University Hospital. Queen Saovabha Memorial Institute, Thai Red Cross Society, Bangkok, Thailand. Department of Medicine, Chulalongkorn University Hospital.

  2. SiRNA miRNA

  3. BMJ 2004;328:1245–48

  4. Targets for gene silencing • Host proteins • Leader RNA (Yang et al 1998,1999) • Viral proteins • N ( Wunner et al., 1991, Wu et al 2002) • P (Morimoto et al. 2005, Blondel et al.,2006) • L (Tordo et al., 1998) • G • M(Finke,Conzelmann 2003) • Viral genome (Barik 2002)

  5. Plasmid siRNA virus 2 viral titers 12 hours 12 hours Plating 70% conf transfection infection 8 hours 24 hours 24 hours 24 hours Cellular RNA Cellular RNA Supernatant Western blot Cellular RNA Supernatant IF Western blot wash Real-time PCR

  6. Pcmv 10-4 24 hr in cell We tested 5 anti-N 2 anti-leader and 3 anti negative strands

  7. SiRNA PS17 CONTROL Control and transfected neuro-2a cells that express the PS17 siRNA were infected with CVS rabies virus for 48 h before they were fixed in acetone and stained with a FITC-labeled anti-N monoclonal antibodies

  8. Conclusions from siRNA studies • Specific viral mRNA and viral replication can be reduced by siRNA • Inhibition of leader RNA and negative strand RNA is less effective than inhibiting N mRNA • All methods that we tested (22 nt siRNA, PCR-based, vector with pol II or pol III promoter ) normally yield only 70% reduction of viral protein mRNA and viral genome • Stable NA cell line expressing anti-N siRNA slow the growth rate of the virus

  9. the siRNA is extremely stringent in its specificity such that a single nucleotide mismatch may abrogate its function To develop therapeutic tool- Need method that is more effective and less stringent

  10. miRNA

  11. miRNA Approximately 60%of miRNAs are expressed independently, 15% of miRNAs are expressed in clusters, and 25% are in introns.

  12. miRNA - 24 hr in cell All anti-N miRNA tested can suppress 85- 95% of viral transcription Not significantly affect house keeper gene Can suppress 85- 98 % of viral genome production

  13. 85 % to 99 % suppression of virus production as measured in supernate

  14. Stained with anti G Ab Stained with anti N Ab Control neuro-2a miRNA-NP1 IF 48 hours after challenged with same amount of CVS virus

  15. miRNA against G mRNA Relative amount of viral RNA Viral genome in cells 24 hours after infection

  16. miRNA against viral genome Relative amount of viral RNA in neuro-2a 72 hours after infection

  17. miRNA against G-mRNA and against negative strand viral genome are not effective

  18. Are 3 copies of same miRNA more effective? Is miRNA against 3 different targets more effective? When N protein is inhibited, is the viral genome more vulnerable to miRNA? Does incorporation of ineffective miRNA to the complex reduce its activities? เ Target 1 Target 2 Target 3 3 targets -> more chances of counter genetic variabilityand mutation

  19. Effect of expressing more than one miRNA as a chain Relative amount of viral RNA Viral RNA in supernatant 48 hours after infection

  20. Effect of expressing more than one miRNA as a chain Relative amount of RNA in cell 24 hours after infection

  21. Effect of expressing effective miRNA together with ineffective miRNA Relative amount of viral RNA in neuro-2a cells 72 hours after challenged with CVS

  22. Chaining miRNA against viral genome with miRNA against NmRNA Relative amount of viral RNA Viral RNA in supernatant 72 hours after infection

  23. Can RNA interference be used for street rabies?

  24. Effect of dsRNA and miRNA (designed against CVS virus) on street virus NmRNA in neuro-2a cells 24 hours after infection 85 % reduction of viral transcription

  25. control dsRNA miRNA-N HEP-Flury –GFP (from Dr. Morimoto) Still reasonably effective against targets that have 2-3 nucleotides different from designed targets

  26. Conclusions • miRNA against N-mRNA is effective in reducing both transcription and replication • miRNA against viral genome alone is not effective • Expressing multiple miRNA as a single premiRNA transcript is possible and will not significantly reduce effectiveness of individual miRNA

  27. Conclusions • miRNA can inhibit (at least) some strains of virus that contain different nucleotide(s) at miRNA target site

  28. Acknowledgements T. HEMACHUDHA N. RATANASETYUTH P.SUPAVONWONG P. VIROJANAPIROM P. KHAWPLOD BIOTEC Thailand

More Related